Lilly resubmits Cymbalta application
Wednesday, June 3, 2009 - 14:35
in Mathematics & Economics
INDIANAPOLIS, June 3 (UPI) -- Eli Lilly and Co. of Indiana has resubmitted an application to the Food and Drug Administration for approval of its antidepressant Cymbalta for chronic pain.